Hyatt Degreen, D.O.
NPI 1235345596 · Hematology & Oncology Physician · Lancaster, PA
Provider details
- NPI number
- 1235345596
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- D.O.
- Sex
- Male
- Sole proprietor
- No
- License
- OT010290 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
20,808 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 2,319 | $7 |
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 2,134 | $8 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 1,665 | $10 |
| Lactate Dehydrogenase (enzyme) Level83615 | 1,661 | $6 |
| Phosphate Level84100 | 1,661 | $5 |
| Uric Acid Level, Blood84550 | 1,661 | $4 |
| Glutamyltransferase (liver Enzyme) Level |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,546 across 59 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-05-15
- Last updated
- 2022-05-02
- Certified
- 2022-05-02
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.